Two major banks have raised their price targets for United Therapeutics, signaling optimism about the stock's future performance.
- BofA and Wells Fargo increased their price targets for United Therapeutics
- This indicates a positive outlook from major financial institutions
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.